Jim Simons Lexicon Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$1.0 - $1.53 $139,920 - $214,077	139,920 Added 51.39%	412,175 $631,000
Q3 2023 Nov 14, 2023	BUY	$1.06 - $2.33 $288,590 - $634,354	272,255 New	272,255 $297,000
Q1 2023 May 12, 2023	SELL	$1.99 - $2.68 $257,525 - $346,818	-129,410 Reduced 32.9%	263,875 $641,000
Q4 2022 Feb 13, 2023	SELL	$1.8 - $2.56 $158,562 - $225,510	-88,090 Reduced 18.3%	393,285 $751,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $933,867 - $1.65 Million	481,375 New	481,375 $1.16 Million
Q2 2022 Aug 12, 2022	SELL	$1.31 - $2.69 $116,296 - $238,807	-88,776 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.95 - $3.89 $173,113 - $345,338	88,776 New	88,776 $186,000
Q3 2021 Nov 12, 2021	SELL	$3.38 - $5.35 $202,039 - $319,796	-59,775 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$4.12 - $5.87 $1.04 Million - $1.48 Million	-252,704 Reduced 80.87%	59,775 $274,000
Q1 2021 May 13, 2021	SELL	$3.45 - $9.09 $2.35 Million - $6.2 Million	-682,500 Reduced 68.59%	312,479 $1.83 Million
Q4 2020 Feb 10, 2021	SELL	$1.05 - $3.67 $669,534 - $2.34 Million	-637,652 Reduced 39.06%	994,979 $3.4 Million
Q3 2020 Nov 13, 2020	SELL	$1.44 - $2.1 $356,503 - $519,901	-247,572 Reduced 13.17%	1,632,631 $2.35 Million
Q2 2020 Aug 13, 2020	BUY	$1.75 - $2.3 $373,808 - $491,291	213,605 Added 12.82%	1,880,203 $3.75 Million
Q1 2020 May 14, 2020	BUY	$1.8 - $4.28 $834,156 - $1.98 Million	463,420 Added 38.52%	1,666,598 $3.25 Million
Q4 2019 Feb 13, 2020	BUY	$3.16 - $5.15 $1.7 Million - $2.77 Million	537,799 Added 80.83%	1,203,178 $4.99 Million
Q3 2019 Nov 13, 2019	BUY	$1.2 - $6.66 $142,365 - $790,129	118,638 Added 21.7%	665,379 $2 Million
Q2 2019 Aug 12, 2019	BUY	$5.35 - $7.11 $306,169 - $406,891	57,228 Added 11.69%	546,741 $3.44 Million
Q1 2019 May 14, 2019	BUY	$4.36 - $7.94 $632,317 - $1.15 Million	145,027 Added 42.1%	489,513 $2.72 Million
Q4 2018 Feb 13, 2019	BUY	$6.15 - $10.51 $2.12 Million - $3.62 Million	344,486 New	344,486 $2.29 Million

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account